"Immunotherapy" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Manipulation of the host's immune system in treatment of disease. It includes both active and passive immunization as well as immunosuppressive therapy to prevent graft rejection.
Below are MeSH descriptors whose meaning is more general than "Immunotherapy".
Below are MeSH descriptors whose meaning is more specific than "Immunotherapy".
This graph shows the total number of publications written about "Immunotherapy" by people in Harvard Catalyst Profiles by year, and whether "Immunotherapy" was a major or minor topic of these publication.
To see the data from this visualization as text,
click here.
Year | Major Topic | Minor Topic | Total |
---|
1994 | 3 | 6 | 9 |
1995 | 6 | 9 | 15 |
1996 | 7 | 4 | 11 |
1997 | 3 | 12 | 15 |
1998 | 2 | 3 | 5 |
1999 | 9 | 7 | 16 |
2000 | 10 | 6 | 16 |
2001 | 5 | 15 | 20 |
2002 | 12 | 15 | 27 |
2003 | 17 | 13 | 30 |
2004 | 16 | 16 | 32 |
2005 | 15 | 20 | 35 |
2006 | 9 | 13 | 22 |
2007 | 19 | 13 | 32 |
2008 | 16 | 20 | 36 |
2009 | 18 | 16 | 34 |
2010 | 20 | 15 | 35 |
2011 | 29 | 16 | 45 |
2012 | 21 | 33 | 54 |
2013 | 40 | 32 | 72 |
2014 | 42 | 28 | 70 |
2015 | 57 | 43 | 100 |
2016 | 78 | 52 | 130 |
2017 | 113 | 56 | 169 |
2018 | 133 | 104 | 237 |
2019 | 109 | 96 | 205 |
2020 | 110 | 120 | 230 |
2021 | 106 | 150 | 256 |
2022 | 32 | 189 | 221 |
2023 | 22 | 171 | 193 |
2024 | 0 | 41 | 41 |
Below are the most recent publications written about "Immunotherapy" by people in Profiles.
-
Immune drivers of physiological and pathological pain. J Exp Med. 2024 May 06; 221(5).
-
Varying Doses of Epicutaneous Immunotherapy With Viaskin Milk vs Placebo in Children With Cow's Milk Allergy: A Randomized Clinical Trial. JAMA Pediatr. 2024 Apr 01; 178(4):345-353.
-
Personalized Cancer Vaccines Directed against Tumor Mutations: Building Evidence from Mice to Humans. Cancer Res. 2024 Apr 01; 84(7):953-955.
-
Immunotherapy time of infusion impacts survival in head and neck cancer: A propensity score matched analysis. Oral Oncol. 2024 Apr; 151:106761.
-
Human lung cancer harbors spatially organized stem-immunity hubs associated with response to immunotherapy. Nat Immunol. 2024 Apr; 25(4):644-658.
-
Genetic Manipulation Approaches to Enhance the Clinical Application of NK Cell-Based Immunotherapy. Stem Cells Transl Med. 2024 Mar 15; 13(3):230-242.
-
MICA-specific nanobodies for diagnosis and immunotherapy of MICA+ tumors. Front Immunol. 2024; 15:1368586.
-
Could the combination of immunotherapy and target therapy be a potential double edge sword for glioblastoma treatment? A correspondence. Neurosurg Rev. 2024 Mar 08; 47(1):105.
-
CD8+ T cell priming that is required for curative intratumorally anchored anti-4-1BB immunotherapy is constrained by Tregs. Nat Commun. 2024 Mar 01; 15(1):1900.
-
The FLRT3-UNC5B checkpoint pathway inhibits T cell-based cancer immunotherapies. Sci Adv. 2024 Mar; 10(9):eadj4698.